{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:03:04Z","timestamp":1774321384187,"version":"3.50.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,27]]},"DOI":"10.1097\/tp.0b013e3182907073","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T17:50:09Z","timestamp":1369158609000},"page":"1485-1490","source":"Crossref","is-referenced-by-count":28,"title":["Contribution of Interferon-\u03b3 Release Assays (IGRAs) to the Diagnosis of Latent Tuberculosis Infection After Renal Transplantation"],"prefix":"10.1097","volume":"95","author":[{"given":"Karine","family":"Hadaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Bridevaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Roux-Lombard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armelle","family":"Delort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Saudan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1469-0691.2009.02949.x","article-title":"Validity of interferon-gamma-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.","volume":"16","author":"Chung","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1542-4758.2010.00470.x","article-title":"Tuberculosis in patients on hemodialysis in an endemic region.","volume":"14","author":"Kazancioglu","year":"2010","journal-title":"Hemodial Int"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2215\/CJN.01790210","article-title":"High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.","volume":"5","author":"Lee","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s15010-008-8082-3","article-title":"High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.","volume":"37","author":"Lee","year":"2009","journal-title":"Infection"},{"key":"R5-10-20210129","first-page":"351","article-title":"Evaluation of performance of Quantiferon assay and tuberculin skin test in end stage renal disease patients receiving hemodialysis.","volume":"34","author":"Maden","year":"2011","journal-title":"New Microbiol"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1053\/j.jrn.2010.06.011","article-title":"Tuberculin skin test, interferon-gamma assay, and T cells subpopulations in hemodialysis patients.","volume":"20","author":"Petrescu","year":"2010","journal-title":"J Ren Nutr"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-3062.2009.00469.x","article-title":"Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.","volume":"12","author":"Seyhan","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/ndt\/gfn748","article-title":"Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.","volume":"24","author":"Triverio","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1086\/501679","article-title":"Tuberculosis in hemodialysis patients in New Jersey: a statewide study.","volume":"20","author":"Simon","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(80)90166-7","article-title":"Tuberculosis in patients with end-stage renal disease.","volume":"68","author":"Andrew","year":"1980","journal-title":"Am J Med"},{"key":"R11-10-20210129","first-page":"14","article-title":"Tuberculosis in dialysis patients.","volume":"17","author":"Belcon","year":"1982","journal-title":"Clin Nephrol"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(79)90240-7","article-title":"Tuberculosis in patients undergoing maintenance hemodialysis.","volume":"67","author":"Lundin","year":"1979","journal-title":"Am J Med"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinte.1980.00330130059017","article-title":"Mycobacteriosis in patients with chronic renal failure.","volume":"140","author":"Rutsky","year":"1980","journal-title":"Arch Intern Med"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000181703","article-title":"Ten years survey of dialysis-associated tuberculosis.","volume":"24","author":"Sasaki","year":"1979","journal-title":"Nephron"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3062.2010.00495.x","article-title":"Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation.","volume":"12","author":"Kim","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11255-004-6251-6","article-title":"Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient.","volume":"36","author":"Agarwal","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/S0041-1345(97)00778-1","article-title":"Problems of diagnosis and treatment of tuberculosis following renal transplantation.","volume":"29","author":"Naqvi","year":"1997","journal-title":"Transplant Proc"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.00000712","article-title":"The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.","volume":"40","author":"Bumbacea","year":"2012","journal-title":"Eur Respir J"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.transproceed.2005.07.041","article-title":"Preliminary report of a nationwide case-control study for identifying risk factors of tuberculosis following renal transplantation.","volume":"37","author":"Basiri","year":"2005","journal-title":"Transplant Proc"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-3156.2011.02816.x","article-title":"Endemic and opportunistic infections in Brazilian solid organ transplant recipients.","volume":"16","author":"Batista","year":"2011","journal-title":"Trop Med Int Health"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/oxfordjournals.ndt.a027395","article-title":"Tuberculosis in renal transplant units.","volume":"11","author":"Drobniewski","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management.","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R27-10-20210129","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infectionUnited States, 2010.","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"R30-10-20210129","first-page":"286","article-title":"Assessment of an interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient.","volume":"140","author":"Hoffmann","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00040007","article-title":"Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients.","volume":"30","author":"Kobashi","year":"2007","journal-title":"Eur Respir J"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2215\/CJN.01280406","article-title":"Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel.","volume":"2","author":"Passalent","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2215\/CJN.09231209","article-title":"Diagnosis of tuberculosis in dialysis patients: current strategy.","volume":"5","author":"Segall","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1523-1755.2004.00586.x","article-title":"Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients.","volume":"65","author":"Sester","year":"2004","journal-title":"Kidney Int"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ndt\/gfg569","article-title":"The value of tuberculin skin testing in haemodialysis patients.","volume":"19","author":"Wauters","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2215\/CJN.01010208","article-title":"Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients.","volume":"3","author":"Winthrop","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data.","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.","volume":"131","author":"Diel","year":"2007","journal-title":"Chest"},{"key":"R39-10-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1472-6963-11-247","article-title":"Systematic review of cost and cost-effectiveness of different TB-screening strategies.","volume":"11","author":"Nienhaus","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"R40-10-20210129","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/annrheumdis-2011-200941","article-title":"Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-gamma release assays under real-life conditions.","volume":"71","author":"Kleinert","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R41-10-20210129","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/cir321","article-title":"Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics.","volume":"53","author":"Mancuso","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R42-10-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/1471-2334-12-285","article-title":"Factors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County.","volume":"12","author":"Sarivalasis","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R43-10-20210129","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/CVI.05299-11","article-title":"Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.","volume":"18","author":"Vassilopoulos","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R44-10-20210129","doi-asserted-by":"crossref","first-page":"e12502","DOI":"10.1371\/journal.pone.0012502","article-title":"Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases.","volume":"5","author":"Adetifa","year":"2010","journal-title":"PLoS One"},{"key":"R45-10-20210129","first-page":"30","article-title":"Do results of the T-SPOT.","volume":"103","author":"Bosshard","year":"2009","journal-title":"TB interferon-gamma release assay change after treatment of tuberculosis Respir Med"},{"key":"R46-10-20210129","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1183\/09031936.00151309","article-title":"Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens.","volume":"36","author":"Chee","year":"2010","journal-title":"Eur Respir J"},{"key":"R47-10-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.rmed.2009.10.006","article-title":"Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.","volume":"104","author":"Lee","year":"2010","journal-title":"Respir Med"},{"key":"R48-10-20210129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1471-2334-10-300","article-title":"Serial interferon-gamma release assays during treatment of active tuberculosis in young adults.","volume":"10","author":"Lee","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R49-10-20210129","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1378\/chest.11-3299","article-title":"Monthly follow-ups of interferon-gamma release assays among healthcare workers in contact with TB patients.","volume":"142","author":"Park","year":"2012","journal-title":"Chest"},{"key":"R50-10-20210129","first-page":"1645","article-title":"Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.","volume":"27","author":"Soysal","year":"2012","journal-title":"TB) or tuberculin skin test Nephrol Dial Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3182907073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:32:27Z","timestamp":1620977547000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201306270-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182907073","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6,27]]}}}